NCT Number: NCT02378376
In Vivo Quantification of Short Chain Fatty Acids Production in the Human Colon
During this project the amount of SCFA produced in the colon after consumption of 2 different 13C-labelled wheat fiber fractions will be quantified.
Looking for future studies?
Notify MeKey information
Conditions
Age range
18 year–65 year
Sex eligibility
All sexes
Study type
Interventional
Phase
Not applicable
Who can participate
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
- Regular diet with 3 meals a day (minimal 5 times a week)
- BMI between 18.5 and 27 kg/m2
Exclusion criteria
- Calorie restricted diet or other special diet during the study or during the last month prior to the study
- Antibiotics in the month prior to the study
- Former surgeries on the gastrointestinal tract, with the exception of an appendectomy
- use of the following types of medications with effects on the gastrointestinal tract during the last 2 weeks prior to the study (spasmolytica, anti-diarrhea, anti-constipation, probiotics)
- Chronic disease of the gastrointestinal tract such as Crohn's disease, ulcerative colitis, irritable bowel syndrome, chronic constipation, chronic frequent diarrhea, clinically relevant lactose intolerance
- Pregnancy, pregnancy desire or breastfeeding
- Diabetes (type 1 and 2)
- Blood donation in the past 3 months prior to the study
- Abnormal hemoglobin (Hb) levels in blood, men must have a Hb level between 14.0 and 18.0 g / dL and women between 12.0 and 16.0 g / dL
- Participation in studies in the past year in which radiation was used.
Treatment and study plan
Dietary fiber enriched bran
Dietary SupplementPrimary outcomes
-
Quantification of acetate, propionate and butyrate production in the colon after consumption of each wheat derived fiber fraction
Time frame: 2 years
Sponsors and collaborators
Lead sponsor
KU Leuven
Other
Registry information
Official study title
In Vivo Quantification of Short Chain Fatty Acids Production in the Human Colon After Consumption of Different Cereal Fractions.
Important dates
- Study start
- 2013
- Primary completion
- 2014
- Study completion
- 2015
- First posted
- Mar 4, 2015
- Registry last updated
- Mar 4, 2015
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Related clinical trials
Published trials that share one or more normalized conditions with this study.
Phase I Study With V-212 Vaccinations in Healthy Adult Volunteers
NCT06975319
Healthy, Immunisation Against Streptococcus Pneumoniae
Ghent, Belgium
View Trial DetailsA Study of LY4086940 in Healthy Participants and Participants With Overweight or Obesity, With or Without Type 2 Diabetes
NCT06945419
Body Weight, Body Weight Changes
Daytona Beach, Florida, United States
View Trial DetailsMAD Study of IA-14069
NCT05533372
Arthritis, Arthritis, Rheumatoid
Lenexa, Kansas, United States
View Trial DetailsA Study of Lepodisiran (LY3819469) in Participants With Normal, Mild, Moderate, or Severe Liver Function
NCT06916078
Digestive System Diseases, Healthy
Miami, Florida, United States
View Trial Details